Symbol="RVMD"
AssetType="Common Stock"
Name="Revolution Medicines Inc"
Description="Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California."
CIK="1628171"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="700 SAGINAW DR, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2737560000"
EBITDA="-271241984"
PERatio="None"
PEGRatio="None"
BookValue="8.96"
DividendPerShare="0"
DividendYield="0"
EPS="-2.92"
RevenuePerShareTTM="0.406"
ProfitMargin="0"
OperatingMarginTTM="-7.91"
ReturnOnAssetsTTM="-0.196"
ReturnOnEquityTTM="-0.345"
RevenueTTM="34816000"
GrossProfitTTM="-217693000"
DilutedEPSTTM="-2.92"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.074"
AnalystTargetPrice="30.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="72.24"
PriceToBookRatio="3.162"
EVToRevenue="53.04"
EVToEBITDA="-6.63"
Beta="1.438"
num_52WeekHigh="31.37"
num_52WeekLow="17.03"
num_50DayMovingAverage="26.02"
num_200DayMovingAverage="23.74"
SharesOutstanding="106313000"
DividendDate="None"
ExDividendDate="None"
symbol="RVMD"
open="25.53"
high="25.68"
low="24.99"
price="25.31"
volume="780444.00"
latest_trading_day="2023-07-26"
previous_close="25.75"
change="-0.44"
change_percent="-1.7087%"
aroon_positive_momentum_days="47"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="47"
Volume_recent_avg="1073620"
Change_recent_avg="0.01"
Delta_recent_avg="1.1"
Variance_recent_avg="0.55"
Change_ratio_recent_avg="0.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="47"
Aroon_momentum_negative="53"
image_negative_thumbnail_id_1="172"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0004.jpeg"
image_negative_thumbnail_id_2="98"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0078.jpeg"
image_neutral_thumbnail_id_1="590"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_neutral_thumbnail_id_2="540"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_positive_thumbnail_id_1="669"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0039.jpeg"
image_positive_thumbnail_id_2="636"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0072.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
